Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release
Abstract Background Cancer cachexia (CAC) reduces patient survival and quality of life. Developments of efficient therapeutic strategies are required for the CAC treatments. This long-term process could be shortened by the drug-repositioning approach which exploits old drugs approved for non-cachexi...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Skeletal Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13395-021-00274-5 |